Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics - InspeCKD

Study identifier:D1843R00351

ClinicalTrials.gov identifier:NCT05953701

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

InspeCKD - Secondary Data Analysis of Patients at Risk for Chronic Kidney Disease (CKD) in German Primary Care Offices to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics

Medical condition

Chronic Kidney Diseases

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

800211

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 26 Jul 2023
Primary Completion Date: 30 Sept 2023
Study Completion Date: 30 Sept 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria